Skip to main content
Premium Trial:

Request an Annual Quote

Stanley Rose, Michael Treble, John Rossi, Eric Dobmeier, Steven Powell, Robert Sacoff

Premium

Stanley Rose, a former vice president of Affymetrix and an Affymetrix fellow, joins Madison, Wisc.-based NimbleGen Systems as president and chief executive officer. He replaces Michael Treble who resigned this summer. Rose, currently chairman of OpGen and a director of GenTel BioSurfaces, both based in Madison, will join NimbleGen’s board of directors. Previously, Rose founded Genetic MicroSystems, which was acquired by Affymetrix in 2000. Rose has held executive positions with PerkinElmer and Applied Biosystems and holds a PhD from the Massachusetts Institute of Technology, as well as an undergraduate degree from Cornell University.


John Rossi joins RNAi company Benitec of Queensland, Australia, as chairman of its scientific advisory board. Rossi is currently director of the Department of Molecular Biology and dean of the Graduate School of Biological Sciences of the Beckman Research Institute of the City of Hope Cancer Center. He received his PhD and conducted his post-doctoral studies at Brown University Medical School.


Eric Dobmeier has been promoted to vice president of corporate affairs, and will retain his position as general counsel, at Seattle Genetics. Dobmeier holds a law degree from the University of California, Berkeley, and an undergraduate degree from Princeton University.


Steven Powell has been named director and partner of the Gilde Biotechnology & Nutrition Fund, a Utrecht, Netherlands-based venture capital firm. Powell was chief executive officer of Biomedix Holdings, a London biopharmaceutical firm.


Robert Sacoff, a partner in the law firm of Pattishall, McAuliffe, Newbury, Hilliard & Geraldson, was elected as chairman of the American Bar Association Section of Intellectual Property Law. He holds a JD from Northwestern University, and an undergraduate degree from the University of Notre Dame.

 

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.